+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

10 Leading Continuous Bioprocessing Companies Shaping the Future Global Market to 2030

Explore the trajectory of continuous bioprocessing in 2025 and beyond with an in-depth look at the industry’s top companies. Discover how transformative innovators are responding to evolving production demands, new regulatory landscapes, and the push for greater quality and scalability. For access to competitive analysis and exclusive growth insights, visit the Continuous Bioprocessing Market by Product Type, Process Stage, Technology, End User, Scale of Production, Bioreactor Type - Global Forecast to 2030 report.

Spotlight on the Leading Continuous Bioprocessing Companies

An in-depth competitive analysis reveals how market leaders are revolutionizing the continuous bioprocessing ecosystem. Their specialized solutions, strategic alliances, and innovative technologies set the pace for the coming decade of biomanufacturing.

1. Thermo Fisher Scientific Inc.

Thermo Fisher Scientific is a global powerhouse in continuous bioprocessing, known for its robust portfolio of single-use systems, scalable bioreactors, and digital process analytics. The company’s commitment to streamlining upstream and downstream production supports manufacturers in achieving real-time control and process intensification, making it a trusted partner for both pharmaceutical giants and emerging biotechnology firms.

2. Danaher Corporation

Danaher Corporation leverages its broad technology base—including subsidiaries like Cytiva and Pall Corporation—to offer advanced continuous chromatography and filtration solutions. Danaher’s focus on precision, scalability, and comprehensive process analytics positions it at the forefront of enabling flexible manufacturing and regulatory compliance across therapeutic modalities.

3. Merck KGaA

Merck KGaA (also known as MilliporeSigma in North America) is recognized for its innovation in bioprocess hardware and process development services. Merck’s expertise in microfiltration, ultrafiltration, and modular continuous processing solutions enables biomanufacturers to enhance efficiency, reduce resource consumption, and optimize production workflows across diverse applications.

4. Sartorius AG

Sartorius AG excels in perfusion and single-use bioreactor technology, empowering clients to achieve enhanced cell culture performance and consistent product quality. Its modular platforms and comprehensive digital integration tools support seamless scale-up, making Sartorius a key driver of global continuous bioprocessing adoption.

5. Lonza Group AG

As a leading contract development and manufacturing organization (CDMO), Lonza Group AG pioneers the integration of continuous processing for biologics, cell, and gene therapy manufacturing. With an emphasis on operational scalability and process flexibility, Lonza delivers solutions that accelerate commercialization and adapt to shifting regulatory frameworks worldwide.

6. FUJIFILM Diosynth Biotechnologies

FUJIFILM Diosynth Biotechnologies specializes in end-to-end continuous bioprocessing, leveraging advanced platform technologies and custom process design. The company’s expertise in viral vector production, protein therapeutics, and innovative upstream/downstream integration makes it a preferred partner for pharmaceutical innovation and next-generation therapies.

7. Repligen Corporation

Repligen Corporation stands out for its pioneering work in continuous filtration, process analytics, and fluid management. Its high-performance ATF (Alternating Tangential Flow) and filtration solutions support intensified processes that boost productivity and ensure consistent manufacturing quality in both pilot and commercial settings.

8. Novasep Holding SAS

Novasep is a recognized leader in continuous chromatography, particularly its simulated moving bed (SMB) systems, which facilitate efficient purification in complex bioprocessing workflows. Novasep’s agile manufacturing solutions address regulatory and cost pressures, empowering companies to achieve high-purity outputs at scale.

9. Applikon Biotechnology B.V.

Applikon Biotechnology B.V. (now part of Getinge) delivers innovative bioreactor systems optimized for continuous process development and scale-up. Its modular, single-use, and stainless steel reactor platforms are engineered for maximum flexibility, supporting a diverse range of therapeutics and research applications.

10. Parker Hannifin Corporation

Parker Hannifin Corporation applies its expertise in fluid management, filtration, and automation to deliver state-of-the-art components for bioprocess intensification. Their robust product lines facilitate integration across multiple bioprocess stages, reinforcing reliability and operational efficiency in continuous production environments.

Conclusion: The Next Era of Continuous Bioprocessing Leadership

Staying ahead in continuous bioprocessing means aligning with the right partners and adopting best-in-class solutions. These industry top players continue to invest in technology, partnerships, and regional strategies that set the pace for global growth and regulatory adaptation. To uncover detailed trends, market segmentation, and actionable strategies for navigating this dynamic landscape, access the full Continuous Bioprocessing Market by Product Type, Process Stage, Technology, End User, Scale of Production, Bioreactor Type - Global Forecast to 2030 report today.